EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HIV-1 Vpr is targeted for degradation by autophagy

Yuexuan Chen, Susanne Klute, Anju Bansal, Konstantin Maria Johannes Sparrer, Ruth Serra-Moreno iD

PLOS Pathogens · 02.03.2026 · 22 (3) · e1014020

DOI: 10.1371/journal.ppat.1014020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 02.03.2026. Verfasst von Yuexuan Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology. University of Rochester Medical Center. Rochester, New York, United States of America. Hauptthemen laut MEDLINE: Autophagy, HIV-1, vpr Gene Products, Human Immunodeficiency Virus, HIV Infections. Die Arbeit nennt 110 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, School of Medicine and Dentistry, University of Rochester.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autophagy is part of the innate immune arsenal to fight viruses, including HIV-1. We previously reported that HIV-1 Gag is targeted for autophagy-mediated degradation. Here, we identify HIV-1 Vpr, an important virulence factor, as an autophagy target in HIV-1 NL4–3, a lab adapted molecular clone. Notably, Vpr proteins from a collection of transmitted/founder viruses (TFVs) were resistant to autophagy. Based on this observation, we identified residues at positions 37, 45, 77, 83–86, 93–94 in NL4–3 Vpr as responsible for its susceptibility to autophagy. Importantly, differences between NL4–3 and TFV Vpr proteins at these positions impact their interaction with the autophagy receptors NDP52, SQSTM1/p62 and TAX1BP1. By engineering NL4–3 molecular clones harboring either autophagy-sensitive or -resistant vpr , we found that in 2D and 3D in vitro systems virus spread was significantly reduced for the virus carrying autophagy-sensitive Vpr. In conclusion, our study identifies Vpr as a novel autophagy target and suggests that Vpr susceptibility to autophagy impacts HIV-1 spread.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AutophagyHIV-1vpr Gene Products, Human Immunodeficiency VirusHIV InfectionsHumans

Substanzen

vpr Gene Products, Human Immunodeficiency Virusvpr protein, Human immunodeficiency virus 1

Autor:innen und Institutionen

  • Department of Microbiology and Immunology. University of Rochester Medical Center. Rochester, New York, United States of America.
  • Institute of Molecular Virology, University of Ulm, Ulm, Germany.
  • Department of Medicine, Infectious Diseases, Heersink School of Medicine. University of Alabama at Birmingham, Birmingham, Alabama, United States of America.
  • German Center for Neurodegenerative Diseases (DZNE), Ulm, Germany.

ORCID-Profile: Ruth Serra-Moreno

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • School of Medicine and Dentistry, University of Rochester
  • Deutsche Forschungsgemeinschaft
  • Bundesministerium für Bildung und Forschung

Zitieren

APA

Chen, Y., Klute, S., Bansal, A., Sparrer, K. M. J., & Serra-Moreno, R. (2026). HIV-1 Vpr is targeted for degradation by autophagy. PLOS Pathogens, 22(3), e1014020. https://doi.org/10.1371/journal.ppat.1014020

Vancouver

Chen Y, Klute S, Bansal A, Sparrer KMJ, Serra-Moreno R. HIV-1 Vpr is targeted for degradation by autophagy. PLOS Pathogens. 2026;22(3):e1014020. doi:10.1371/journal.ppat.1014020

BibTeX
@article{Chen2026,
  author = {Chen, Yuexuan and Klute, Susanne and Bansal, Anju and Sparrer, Konstantin Maria Johannes and Serra-Moreno, Ruth},
  title = {HIV-1 Vpr is targeted for degradation by autophagy},
  journal = {PLOS Pathogens},
  year = {2026},
  volume = {22},
  number = {3},
  pages = {e1014020},
  doi = {10.1371/journal.ppat.1014020}
}
Kostenlos starten →